Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Accumulated Expenses (2017 - 2025)

Historic Accumulated Expenses for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $59.5 million.

  • Inspire Medical Systems' Accumulated Expenses rose 1942.43% to $59.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $59.5 million, marking a year-over-year increase of 1942.43%. This contributed to the annual value of $59.5 million for FY2025, which is 1942.43% up from last year.
  • Inspire Medical Systems' Accumulated Expenses amounted to $59.5 million in Q4 2025, which was up 1942.43% from $51.6 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Accumulated Expenses registered a high of $59.5 million during Q4 2025, and its lowest value of $10.4 million during Q1 2021.
  • For the 5-year period, Inspire Medical Systems' Accumulated Expenses averaged around $30.6 million, with its median value being $29.5 million (2022).
  • The largest annual percentage gain for Inspire Medical Systems' Accumulated Expenses in the last 5 years was 6832.18% (2023), contrasted with its biggest fall of 337.4% (2023).
  • Inspire Medical Systems' Accumulated Expenses (Quarter) stood at $20.5 million in 2021, then soared by 67.88% to $34.3 million in 2022, then grew by 14.35% to $39.3 million in 2023, then increased by 26.86% to $49.8 million in 2024, then increased by 19.42% to $59.5 million in 2025.
  • Its Accumulated Expenses stands at $59.5 million for Q4 2025, versus $51.6 million for Q3 2025 and $40.2 million for Q2 2025.